stilnoct 10 mg filmovertrukne tabletter
sanofi a/s - zolpidem tartrat - filmovertrukne tabletter - 10 mg
surgamyl 300 mg tabletter
sanofi a/s - tiaprofensyre - tabletter - 300 mg
tilavist 20 mg/ml øjendråber
sanofi a/s - natriumnedokromil - øjendråber - 20 mg/ml
venlafaxin "medical valley" 150 mg depottabletter
medical valley invest ab - venlafaxinhydrochlorid - depottabletter - 150 mg
venlafaxin "medical valley" 225 mg depottabletter
medical valley invest ab - venlafaxinhydrochlorid - depottabletter - 225 mg
venlafaxin "medical valley" 75 mg depottabletter
medical valley invest ab - venlafaxinhydrochlorid - depottabletter - 75 mg
xatral 2,5 mg filmovertrukne tabletter
sanofi a/s - alfuzosinhydrochlorid - filmovertrukne tabletter - 2,5 mg
zynquista
guidehouse germany gmbh - sotagliflozin - diabetes mellitus (sukkersyge), type 1 - narkotika anvendt i diabetes - zynquista er indiceret som et supplement til insulin terapi til at forbedre glykæmisk kontrol hos voksne med type 1 diabetes mellitus med et body mass index (bmi) ≥ 27 kg/m2, som ikke har opnået tilstrækkelig glykæmisk kontrol på trods af den optimale insulin terapi.
nexviadyme
sanofi b.v. - avalglucosidase alfa - glycogen opbevaring sygdom type ii - andre alimentary tract and metabolism produkter, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).
xenpozyme
sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - andre alimentary tract and metabolism produkter, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.